Agilon Health, Inc.
AGL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,435,321 | $1,394,982 | $1,532,782 | $1,522,486 |
| % Growth | 2.9% | -9% | 0.7% | – |
| Cost of Goods Sold | $1,510,397 | $1,447,409 | $1,482,060 | $1,560,741 |
| Gross Profit | -$75,076 | -$52,427 | $50,722 | -$38,255 |
| % Margin | -5.2% | -3.8% | 3.3% | -2.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $56,281 | $65,956 | $59,755 |
| SG&A Expenses | $52,106 | $56,281 | $65,956 | $59,755 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $7,319 | $6,876 | $10,090 |
| Operating Expenses | $52,106 | $63,600 | $72,832 | $69,845 |
| Operating Income | -$127,182 | -$116,027 | -$22,110 | -$108,100 |
| % Margin | -8.9% | -8.3% | -1.4% | -7.1% |
| Other Income/Exp. Net | $16,644 | $11,719 | $20,418 | $3,427 |
| Pre-Tax Income | -$110,538 | -$104,308 | -$1,692 | -$104,673 |
| Tax Expense | -$331 | $62 | $196 | $1,757 |
| Net Income | -$110,207 | -$104,370 | $12,112 | -$105,790 |
| % Margin | -7.7% | -7.5% | 0.8% | -6.9% |
| EPS | -0.266 | -0.25 | 0.03 | -0.26 |
| % Growth | -6.4% | -933.3% | 111.5% | – |
| EPS Diluted | -0.266 | -0.25 | 0.03 | -0.26 |
| Weighted Avg Shares Out | 414,465 | 413,836 | 412,936 | 412,044 |
| Weighted Avg Shares Out Dil | 414,465 | 413,836 | 412,936 | 412,044 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,838 | $1,572 | $1,515 | $1,574 |
| Depreciation & Amortization | $7,430 | $7,319 | $6,876 | $6,494 |
| EBITDA | -$101,270 | -$95,417 | $6,699 | -$96,605 |
| % Margin | -7.1% | -6.8% | 0.4% | -6.3% |